Group One Trading
TAK icon

Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History

Group One Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$546K Buy
+34,035
New +$563K ﹤0.01% 3414
2025
Q3 		– Sell
-147
Closed -$2.18K – 9127
2025
Q2 		$2.27K Sell
147
-100
-40% -$1.48K ﹤0.01% 7381
2025
Q1 		$3.67K Sell
247
-28
-10% -$392 ﹤0.01% 6773
2024
Q4 		$3.64K Sell
275
-7,607
-97% -$104K ﹤0.01% 6548
2024
Q3 		$112K Buy
+7,882
New +$112K ﹤0.01% 4083
2023
Q3 		– Sell
-4,975
Closed -$77K – 8288
2023
Q2 		$78.2K Sell
4,975
-10,963
-69% -$180K ﹤0.01% 4864
2023
Q1 		$263K Buy
+15,938
New +$254K ﹤0.01% 3413
2022
Q4 		– Sell
-18,386
Closed -$257K – 8066
2022
Q3 		$238K Sell
18,386
-35,346
-66% -$491K ﹤0.01% 3966
2022
Q2 		$754K Buy
53,732
+31,403
+141% +$448K ﹤0.01% 3020
2022
Q1 		$320K Buy
+22,329
New +$328K ﹤0.01% 4304
2021
Q1 		– Sell
-39,227
Closed -$706K – 8012
2020
Q4 		$714K Buy
+39,227
New +$688K ﹤0.01% 2949
2019
Q2 		– Sell
-19,202
Closed -$349K – 5376
2019
Q1 		$391K Buy
+19,202
New +$386K ﹤0.01% 2152

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Group One Trading's TAK Position: Q2 2026 in Review

Group One Trading opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 34,035 shares worth $546K. The stake represents ﹤0.01% of the portfolio and ranks #3414 among its holdings. This is a return to the name: Group One Trading previously reported a position in TAK as recently as Q2 2025.

Group One Trading first reported a position in TAK in Q1 2019 and has held it in 12 quarters since. The position peaked at $754K in Q2 2022. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Group One Trading held 34,035 shares of Takeda Pharmaceutical worth $546K as of Q2 2026.
  • Takeda Pharmaceutical was a new Group One Trading position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3414 holding.
  • Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 12 quarters since.
  • Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.